SYMMETRYRX Trademark
SYMMETRYRX is a USPTO trademark filed by SymmetryRx LLC. Status: Abandoned.
Trademark Facts
| Mark | SYMMETRYRX |
|---|---|
| Serial Number | 97456625 |
| Status | Abandoned |
| Filing Date | 2022-06-14 |
| Mark Type | Word |
| Nice Classes | 042 (Software & IT) |
| Owner | SymmetryRx LLC |
| Attorney of Record | Frank J. Bonini, Jr. |
| Prosecution Events | 21 |
| Latest Event | ABN2 on 2026-02-17 |
Goods & Services
Platform as a service (PAAS) featuring computer software platforms for enabling sponsoring pharmaceutical manufacturers to communicate with prospective customer patients about prescription medications; Platform as a service (PAAS) featuring computer software platforms for administering and managing patient support services, namely, computer software platforms for providing patient information and resources for medications, conditions, or other healthcare issues; Platform as a service (PAAS) featuring computer software platforms for managing electronic prescription work flow and electronic healthcare records, namely, computer software platforms for requesting and fulfilling online orders for pharmaceutical samples, and for viewing, editing, and storing electronic healthcare records; Platform as a service (PAAS) featuring computer software platforms for operating a prescription eligibility program for patients and prescribers, namely, computer software platforms for qualifying patients for discounts for prescriptions; Platform as a service (PAAS) featuring computer software platforms for communicating offers for prescriptions to prospective customer patients; Platform as a service (PAAS) featuring computer software platforms for managing patient consents, namely, computer software platforms for obtaining and storing patient consents; Platform as a service (PAAS) featuring computer software platforms for recording patient consents; Platform as a service (PAAS) featuring computer software platforms for managing prescription routing for fulfillment and delivery of prescriptions to patients; Platform as a service (PAAS) featuring computer software platforms for providing patients with medication information, educational materials, and adherence support services sponsored by the manufacturer from the program pharmacy; Platform as a service (PAAS) featuring computer software platforms for analyzing and optimizing patient selection and prescription program management, namely, computer software platforms for matching patients with potential discount programs; Platform as a service (PAAS) featuring computer software platforms for providing data security in accordance with applicable regulations in the field of prescription medications
Recent Prosecution Activity
| Date | Document | Type |
|---|---|---|
| 2026-02-17 | ABANDONMENT-Notice | ABN |
| 2025-10-15 | Final Action | FREF |
| 2023-06-28 | Suspension Letter | SUSLT |
| 2023-04-12 | Amendment and Mail Process Complete | AMC |
| 2023-04-10 | Response to Office Action | ROA |
| 2022-10-09 | Non-Final Action | NFIN |
USPTO Refusals on Record
- standard_loc